Advertisement
Screener

SAREPTA THERAPEUTICS, INC. (SRPT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.8 / 5 stars · 68/120 Roast Me

SAREPTA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

SAREPTA THERAPEUTICS, INC. (SRPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 80.00% for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2013-05-09

  • SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2013-03-31 was 80.00%, a 0.38% increase year-over-year.
  • SAREPTA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2012-03-31 was 79.70%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month
2013-03-3180.00%
10-Q · filed 2013-05-09
2012-03-3179.70%
10-Q · filed 2013-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77